NMTC Company Profile and Key Details

Q: Who are the executives of NMTC?

Mr. Hijaz HarisVice President of MarketingMr. David A. Rosa M.D.Pres, Chief Executive Officer & DirectorMr. Ronald W. McClurgChief Financial OfficerMr. Mark ChristiansonCo-Founder, Bus. Devel. Director & Medical Sales LiaisonMr. Steven MertensChief Technology OfficerMr. Anthony MillarVice President of Operations & Supply Chain Planning, Procurement, Manufacturing, Distribution and Logistics

NASDAQ : NMTC

NeuroOne Medical Technologies

$1.58

-0.08-4.82%

At Close 4:00 PM

$1.70

+0.12+7.59%

After-Market 08:30 PM

59.35

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

NeuroOne Medical Technologies Corporation (NMTC) stock declined over -4.82%, trading at $1.58 on NASDAQ, down from the previous close of $1.66. The stock opened at $1.65, fluctuating between $1.56 and $1.67 in the recent session.

Stock Snapshot

1.66

Prev. Close

13.75M

Market Cap

1.56

Day Low

-1.66

P/E Ratio

-0.95

EPS (TTM)

-0.57

Cash Flow per Share

1.65

Open

8.7M

Number of Shares

1.67

Day High

87.38%

Free Float in %

0.18

Book Value

225.07K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	1.65	1.67	1.56	1.58	225.22K
Sep 09, 2026	1.71	1.73	1.63	1.66	99.7K
Sep 08, 2026	1.68	1.73	1.58	1.69	274.28K
Sep 04, 2026	1.65	1.66	1.57	1.62	81.1K
Sep 03, 2026	1.68	1.73	1.62	1.66	32.34K
Sep 02, 2026	1.60	1.80	1.58	1.67	203.24K
Sep 01, 2026	1.67	1.72	1.60	1.61	71.82K
Aug 31, 2026	1.70	1.81	1.62	1.70	258.03K
Aug 28, 2026	1.89	1.96	1.70	1.77	461.27K
Aug 27, 2026	2.16	3.49	1.89	1.98	13.8M
Aug 26, 2026	2.16	2.17	2.00	2.00	10.39K
Aug 25, 2026	2.16	2.20	2.10	2.16	24.14K
Aug 24, 2026	2.00	2.24	1.90	2.14	58.71K
Aug 21, 2026	2.15	2.15	2.01	2.03	34.97K
Aug 20, 2026	2.18	2.31	2.15	2.15	58.95K
Aug 19, 2026	1.88	2.37	1.87	2.18	85.76K
Aug 18, 2026	1.90	2.09	1.82	1.88	47.3K
Aug 17, 2026	1.94	1.98	1.85	1.88	30.47K
Aug 14, 2026	1.90	2.04	1.75	1.94	94.08K
Aug 13, 2026	1.51	1.93	1.46	1.83	296.71K

Contact Details

Eden Prairie, MN 55344

United States

https://nmtc1.com 952 426 1383

About Company

NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.

Stock Peers

BRKRP

-11.09-2.73%

Bruker Corporation$395.14 SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

-1.19-0.43%

UFP Technologies, Inc.$277.40 MASI

Masimo Corporation$179.95 ALGN

-2.2-1.44%

Align Technology, Inc.$150.72 PODD

-3.24-2.35%

Insulet Corp.$134.68 IRTC

-6.69-5.60%

iRhythm Technologies, Inc.$112.88 TMDX

-1.36-1.57%

TransMedics Group, Inc.$85.04 DXCM

0.63+0.75%

DexCom, Inc.$84.51 IRMD

-1.69-2.02%

IRadimed Corporation$81.87

Company Overview

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) closed at $1.58 USD, losing -$0.08 (-4.82%) from the previous close of $1.66. The stock is currently mid-range between its 52-week high and low $1.42 and $6.96. With a market capitalization of about $13.75 million, NeuroOne Medical Technologies Corporation is classified as a micro-cap and shows lower-than-market volatility (beta ~0.64). Key stats such as the average daily volume over the past year has been around 296.19 thousand shares, in line with its 52-week average. Headquartered in Eden Prairie, MN, NeuroOne Medical Technologies Corporation operates in the Healthcare sector and the Medical - Devices industry. Led by CEO David A. Rosa, the company employs approximately 18 people and listed since March 15, 2018. NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -9.56%, SMA50 -13.71%, SMA200 -10.05%). The stock’s 14-day RSI is 40.42 (neutral), while the ATR of 0.06 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -40.47% below its high and over 74.63% above its low. Average 10-day trading volume of 155.72 thousand shares is below the 3-month average of 287.93 thousand, indicating normal recent market interest.

Valuation Metrics

NeuroOne Medical Technologies Corporation trades at a P/E ratio of -1.76, slightly below the S&P 500 average, with a price-to-sales ratio of 1.4 and a price-to-book ratio of 3.69 trading at moderately above to book value. The P/FCF stands at -1.95, also above market averages.

Dividend & Fair Value

NeuroOne Medical Technologies Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.04. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

NeuroOne Medical Technologies Corporation generated EPS of -$0.16 over the past year. Five-year average earnings growth is 48.66%. Wall Street analysts project EPS growth of 30.66% annually over the next five years. The latest quarter delivered EPS of -$0.28. The next quarter is forecast at -$0.03. Next year's EPS is expected at $38.64. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $8.00 to $1.50. The high target offers 406.33% upside. The low target suggests -5.06% downside. The mean target is $4.75. This offers 200.63% upside. NeuroOne Medical Technologies Corporation earnings surprise history is a mixed track record. The quarter that ended August 13, 2026, missed forecasts by -52.0%. The prior quarter beat by 10.29%. Over the last six quarters, Apple has recorded several small beats. These include -40.0% in August 14, 2025.

Shareholding & Insider Activity

NeuroOne Medical Technologies Corporation has 9.11 million shares outstanding. The public float is 6.27 million shares, elevated short interest at 0.46% of float. This equals 38.70 thousand shares. The short ratio is 0.78 days. Institutional investors hold 30.76% of the float. Insiders own 26.4%. Samad Amer holds 3.52 million shares, Fredrickson Wade has 2.61 million shares and Rosa David A has 1.16 million shares. Over the past six months, insider transactions show net selling. They sold 26.28 thousand shares across 4 transactions.

Financial & Profitability Overview

Over the trailing twelve months, NeuroOne Medical Technologies generated $12.10M in revenue, or $0.30 per share. Gross margin was 67.30%, operating margin -34.94%, and net profit margin -29.80%. Returns are negative, with ROA at -33.43% and ROE at -50.98%.
On valuation metrics, NeuroOne Medical Technologies trades at a P/E of -1.76, P/S of 1.40 and P/B of 3.69. The current ratio is 2.84 and quick ratio is 1.71. Operationally, the company’s inventory turnover is 1.94 and cash conversion cycle is 154.14 days. Debt-to-equity is 0.02, supported by a cash flow-to-debt ratio of -96.18.

Quarterly Financial Highlights

For the quarter ended Sep 30, 2025, NeuroOne Medical Technologies posted revenue of $12.10M, down slightly from $3.45M in the prior quarter. Gross profit was $8.14M (margin 67.30%). Operating income was - $4.23M (margin -34.9%). Net income was- $3.61M (EPS - $0.09).
The company ended the quarter with $6.57M in cash and short-term investments, a total debt of $266.81K, and net debt of - $6.30M. Total assets were $10.79M, with equity of $7.07M. Financials further reflected weakness, with operating cash flow of - $2.84M, free cash flow of - $2.92M, and capital expenditures of - $81.74K.

Price Forecast & Outlook

Our AI price prediction model suggests that NeuroOne Medical Technologies Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 9.49%, with price expected at $1.73 by September 23, 2026, within a range of $1.50 to $1.95 3-Month Outlook: Projected fall of -58.23%, reaching $0.66 by December 08, 2026, with a range of $0.47 to $0.85. 1-Year Outlook: Projected gain of 27.85%, with price at $2.02 by September 10, 2027, within a range of $0.00 to $0.54.

Key Takeaways

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) shares are up 18.67% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows NeuroOne Medical Technologies Corporation trading at a premium to the broader market with a P/E of -1.76. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $3.34, suggesting 111.39% upside. Our AI forecast model points to short-term strength (9.49% over two weeks), a medium-term fall (-58.23% over three months), and a longer-term gain (27.85% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current NeuroOne Medical Technologies Corporation (NMTC) stock price?

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) stock price is $1.58 in the last trading session. During the trading session, NMTC stock reached the peak price of $1.67 while $1.56 was the lowest point it dropped to. The percentage change in NMTC stock occurred in the recent session was -4.82% while the dollar amount for the price change in NMTC stock was - $0.08.

NMTC's industry and sector of operation?

The NASDAQ listed NMTC is part of Medical - Devices industry that operates in the broader Healthcare sector. NeuroOne Medical Technologies Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NMTC?

Mr. Hijaz Haris
Vice President of Marketing
Mr. David A. Rosa M.D.
Pres, Chief Executive Officer & Director
Mr. Ronald W. McClurg
Chief Financial Officer
Mr. Mark Christianson
Co-Founder, Bus. Devel. Director & Medical Sales Liaison
Mr. Steven Mertens
Chief Technology Officer
Mr. Anthony Millar
Vice President of Operations & Supply Chain Planning, Procurement, Manufacturing, Distribution and Logistics

How NMTC did perform over past 52-week?

NMTC's closing price is 11.03% higher than its 52-week low of $1.42 where as its distance from 52-week high of $6.96 is -77.3%.

How many employees does NMTC have?

Number of NMTC employees currently stands at 18.

Link for NMTC official website?

Official Website of NMTC is: https://nmtc1.com

How do I contact NMTC?

NMTC could be contacted at phone 952 426 1383 and can also be accessed through its website. NMTC operates from 7599 Anagram Drive, Eden Prairie, MN 55344, United States.

How many shares of NMTC are traded daily?

NMTC stock volume for the day was 225.07K shares. The average number of NMTC shares traded daily for last 3 months was 296.19K.

What is the market cap of NMTC currently?

The market value of NMTC currently stands at $13.75M with its latest stock price at $1.58 and 8.7M of its shares outstanding.

Employees	18
Beta	0.64
Sales or Revenue	$12.10M
5Y Sales Change%	-0.363%
Fiscal Year Ends	September
Sector	Healthcare
Industry	Medical - Devices

NMTC Company Profile and Key Details

NeuroOne Medical Technologies

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Technical Performance

Valuation Metrics

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Price Forecast & Outlook

Key Takeaways